Noticias de última hora

Research Analysts Set CVS Health Corporation (NYSE:CVS) Price Target at $93.105

BNP Paribas Arbitrage SA now owns 352,871 shares of the pharmacy operator's stock valued at $33,784,000 after buying an additional 55,145 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of CVS Health Corporation by 2.3% in the second quarter.

China Cord Blood Corporation (NYSE:CO) showed bullish move with gain of +11.88% after exchanging volume of 763.68 thousand shares in last trading session ended on 12/30/2016. ATR value of corporation was 1.34. Legal & General Group Plc now owns 4,961,136 shares of the pharmacy operator's stock worth $514,632,000 after buying an additional 92,196 shares in the last quarter. Expected growth of CVS Health Corporation (NYSE:CVS) for the next year 5 years is 10.69 percent (per annum), as compared to 14.4 percent (per annum) in the past 5 years.

The Relative Volume of the company is 0.51 and Average Volume (3 months) is 8.45 million. The firm shows a 20-Day Simple Moving Average of 1.21% with a 200-Day Simple Moving Average of -12.38%. The high end of the revenue guidance is $47.51 Billion and the low end is $44.54 Billion. The stock's market capitalization is 84.15B.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 8th. While the actual EPS the company reported in the same quarter previous year was 1.53/share. The Return on Equity (ROE) value stands at 13.2%. Firm quarterly performance is -40.86%. During the same quarter in the prior year, the company posted $1.28 EPS. The firm's revenue for the quarter was up 15.5% compared to the same quarter a year ago.

Читайте также: Orrego tilda de "impropia" e "irresponsable" idea de Lavín sobre guardias municipales

Average Revenue Estimate for the current quarter is 9.69 Billion, according to consensus forecast of 13 analysts. Stockholders of record on Tuesday, January 24th will be paid a $0.50 dividend. CVS's value Change from Open was at -0.73% with a Gap of -0.01%. The rating was initiated by Robert W. Baird with "Outperform" on Friday, January 22. It has a dividend yield of 2.53% while the payout ratio is 38.60%.

WARNING: This article was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another domain, it was copied illegally and republished in violation of United States & global trademark & copyright legislation. The original version of this story can be read at

A number of Wall Street analysts recently commented on the stock.

23 analysts projected Price Targets for CVS Health Corporation. Finally, Vetr raised shares of CVS Health Corporation from a "hold" rating to a "buy" rating and set a $94.49 target price for the company in a research note on Monday, October 10th. The 1-year price target of the company is 87.1. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Leerink Swann reissued a "buy" rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of "Buy" and a consensus price target of $101.53. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2018 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Artículos relacionados